Sung Kai-Feng, Odinokova Irina V, Mareninova Olga A, Rakonczay Zoltán, Hegyi Péter, Pandol Stephen J, Gukovsky Ilya, Gukovskaya Anna S
Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Exp Cell Res. 2009 Jul 1;315(11):1975-89. doi: 10.1016/j.yexcr.2009.01.009. Epub 2009 Jan 24.
Acinar cells in pancreatitis die through apoptosis and necrosis, the roles of which are different. The severity of experimental pancreatitis correlates directly with the extent of necrosis and inversely, with apoptosis. Apoptosis is mediated by the release of cytochrome c into the cytosol followed by caspase activation, whereas necrosis is associated with the mitochondrial membrane potential (DeltaPsim) loss leading to ATP depletion. Here, we investigate the role of Bcl-2 proteins in apoptosis and necrosis in pancreatitis. We found up-regulation of prosurvival Bcl-2 proteins in pancreas in various experimental models of acute pancreatitis, most pronounced for Bcl-xL. This up-regulation translated into increased levels of Bcl-xL and Bcl-2 in pancreatic mitochondria. Bcl-xL/Bcl-2 inhibitors induced DeltaPsim loss and cytochrome c release in isolated mitochondria. Corroborating the results on mitochondria, Bcl-xL/Bcl-2 inhibitors induced DeltaPsim loss, ATP depletion and necrosis in pancreatic acinar cells, both untreated and hyperstimulated with CCK-8 (in vitro pancreatitis model). Together Bcl-xL/Bcl-2 inhibitors and CCK induced more necrosis than either treatment alone. Bcl-xL/Bcl-2 inhibitors also stimulated cytochrome c release in acinar cells leading to caspase-3 activation and apoptosis. However, different from their effect on pronecrotic signals, the stimulation by Bcl-xL/Bcl-2 inhibitors of apoptotic responses was less in CCK-treated than control cells. Therefore, Bcl-xL/Bcl-2 inhibitors potentiated CCK-induced necrosis but not apoptosis. Correspondingly, transfection with Bcl-xL siRNA stimulated necrosis but not apoptosis in the in vitro pancreatitis model. Further, in animal models of pancreatitis Bcl-xL up-regulation inversely correlated with necrosis, but not apoptosis. Results indicate that Bcl-xL and Bcl-2 protect acinar cells from necrosis in pancreatitis by stabilizing mitochondria against death signals. We conclude that Bcl-xL/Bcl-2 inhibition would aggravate acute pancreatitis, whereas Bcl-xL/Bcl-2 up-regulation presents a strategy to prevent or attenuate necrosis in pancreatitis.
胰腺炎中的腺泡细胞通过凋亡和坏死死亡,二者作用不同。实验性胰腺炎的严重程度与坏死程度直接相关,与凋亡程度呈负相关。凋亡由细胞色素c释放到胞质溶胶中随后激活半胱天冬酶介导,而坏死与线粒体膜电位(ΔΨm)丧失导致ATP耗竭有关。在此,我们研究Bcl-2蛋白在胰腺炎凋亡和坏死中的作用。我们发现在各种急性胰腺炎实验模型中,胰腺中促生存Bcl-2蛋白上调,其中Bcl-xL最为明显。这种上调转化为胰腺线粒体中Bcl-xL和Bcl-2水平升高。Bcl-xL/Bcl-2抑制剂在分离的线粒体中诱导ΔΨm丧失和细胞色素c释放。与线粒体结果一致,Bcl-xL/Bcl-2抑制剂在未处理的和用CCK-8过度刺激的胰腺腺泡细胞(体外胰腺炎模型)中诱导ΔΨm丧失、ATP耗竭和坏死。Bcl-xL/Bcl-2抑制剂和CCK共同诱导的坏死比单独任何一种处理都更多。Bcl-xL/Bcl-2抑制剂还刺激腺泡细胞中的细胞色素c释放,导致半胱天冬酶-3激活和凋亡。然而,与它们对促坏死信号的作用不同,Bcl-xL/Bcl-2抑制剂对凋亡反应的刺激在CCK处理的细胞中比对照细胞中更少。因此,Bcl-xL/Bcl-2抑制剂增强了CCK诱导的坏死,但未增强凋亡。相应地,在体外胰腺炎模型中,用Bcl-xL siRNA转染刺激了坏死,但未刺激凋亡。此外,在胰腺炎动物模型中,Bcl-xL上调与坏死呈负相关,但与凋亡无关。结果表明,Bcl-xL和Bcl-2通过稳定线粒体抵抗死亡信号来保护腺泡细胞免受胰腺炎中的坏死。我们得出结论,抑制Bcl-xL/Bcl-2会加重急性胰腺炎,而上调Bcl-xL/Bcl-2是预防或减轻胰腺炎坏死的一种策略。